Taken together, these data uncover a regulatory mechanism by which AR deletion induces IGFBP3 expression in Gli1-lineage FB to block IGF1-signaling activation, further hindering prostatic basal epithelial cell-mediated oncogenesis and tumor development. The gene discussed is IGF1; the disease is neoplasm.